Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials
Ole Köhler‐Forsberg(Harvard University), Andrew A. Nierenberg(Andrews University), Mauricio Tohen(Universidade Federal do Rio Grande do Sul), Richard C. Shelton(University of Alabama at Birmingham), Melvin G. McInnis(University of Michigan), Joseph R. Calabrese(University Hospitals of Cleveland), Vicki Fung(Massachusetts General Hospital), Lindsay Overhage(Cambridge Health Alliance), Thilo Deckersbach(Massachusetts General Hospital), Terence A. Ketter(Universidade Federal do Rio Grande do Sul), Dan V. Iosifescu(Allen Institute for Brain Science), Michael J. Ostacher(VA Palo Alto Health Care System), Susan L. McElroy(Universidade Federal do Rio Grande do Sul), Charles L. Bowden(The University of Texas at San Antonio Health Science Center), Michael E. Thase(The University of Texas at San Antonio Health Science Center), Louisa G. Sylvia(Massachusetts General Hospital), James H. Kocsis(Cornell University), Edward S. Friedman(University of Pittsburgh)
Cited by 8
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k
Mood Disorders in the Medically Ill: Scientific Review and Recommendations
|Biological Psychiatry|2005|1.1k
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
|New England Journal of Medicine|2007|925
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754